260 related articles for article (PubMed ID: 22314103)
1. Concordant promoter methylation of transforming growth factor-beta receptor types I and II occurs early in esophageal squamous cell carcinoma.
Dong Z; Guo W; Guo Y; Kuang G; Yang Z
Am J Med Sci; 2012 May; 343(5):375-81. PubMed ID: 22314103
[TBL] [Abstract][Full Text] [Related]
2. Concordant repression and aberrant methylation of transforming growth factor-beta signaling pathway genes occurs early in gastric cardia adenocarcinoma.
Guo W; Dong Z; Guo Y; Kuang G; Yang Z; Shan B
Mol Biol Rep; 2012 Oct; 39(10):9453-62. PubMed ID: 22722999
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
[TBL] [Abstract][Full Text] [Related]
4. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma.
Guo W; Zhang M; Shen S; Guo Y; Kuang G; Yang Z; Dong Z
Cancer; 2014 Aug; 120(16):2412-23. PubMed ID: 24798237
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
7. TGF-β1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma.
Bu F; Liu X; Li J; Chen S; Tong X; Ma C; Mao H; Pan F; Li X; Chen B; Xu L; Li E; Kou G; Han J; Guo S; Zhao J; Guo Y
Oncotarget; 2015 Feb; 6(4):2120-33. PubMed ID: 25544767
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ
Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812
[TBL] [Abstract][Full Text] [Related]
9. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.
Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z
Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P
Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344
[TBL] [Abstract][Full Text] [Related]
11. TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case-control analysis in a Chinese population.
Jin G; Deng Y; Miao R; Hu Z; Zhou Y; Tan Y; Wang J; Hua Z; Ding W; Wang L; Chen W; Shen J; Wang X; Xu Y; Shen H
J Cancer Res Clin Oncol; 2008 Mar; 134(3):345-51. PubMed ID: 17680270
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
[TBL] [Abstract][Full Text] [Related]
13. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
[TBL] [Abstract][Full Text] [Related]
14. Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.
Kohan-Ivani K; Gabler F; Selman A; Vega M; Romero C
J Cancer Res Clin Oncol; 2016 Jan; 142(1):47-58. PubMed ID: 26091707
[TBL] [Abstract][Full Text] [Related]
15. Aberrant promoter methylation of the TPEF gene in esophageal squamous cell carcinoma.
Zhao BJ; Tan SN; Cui Y; Sun DG; Ma X
Dis Esophagus; 2008; 21(7):582-8. PubMed ID: 19040536
[TBL] [Abstract][Full Text] [Related]
16. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus.
Natsugoe S; Xiangming C; Matsumoto M; Okumura H; Nakashima S; Sakita H; Ishigami S; Baba M; Takao S; Aikou T
Clin Cancer Res; 2002 Jun; 8(6):1838-42. PubMed ID: 12060625
[TBL] [Abstract][Full Text] [Related]
17. Low expression of transforming growth factor beta-1 in cancer tissue predicts a poor prognosis for patients with stage III rectal cancers.
Chun HK; Jung KU; Choi YL; Hong HK; Kim SH; Yun SH; Kim HC; Lee WY; Cho YB
Oncology; 2014; 86(3):159-69. PubMed ID: 24643220
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation-associated inactivation of retinoic acid receptor beta in human esophageal squamous cell carcinoma.
Wang Y; Fang MZ; Liao J; Yang GY; Nie Y; Song Y; So C; Xu X; Wang LD; Yang CS
Clin Cancer Res; 2003 Nov; 9(14):5257-63. PubMed ID: 14614007
[TBL] [Abstract][Full Text] [Related]
19. [Functional significance of TGF-beta1 signal transduction pathway in oral squamous cell carcinoma].
Wang XM; Liu CM; Zhang CR; Xu XG; Fu SB
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):28-32. PubMed ID: 19538865
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
